Progesterone receptor agonists and antagonists

被引：6
|
作者：
Allan, G [1 ]
Macielag, M [1 ]
机构：
[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 1999年 / 9卷 / 07期
关键词：
contraception; endometriosis; leiomyomata; mifepristone; progestin;
D O I：
10.1517/13543776.9.7.955
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Steroidal progestin agonists have long been used in oral contraceptives, and the progestin antagonist mifepristone is used as an abortifacient. Progestin antagonists are also likely to be useful for treating breast cancer and various gynaecological disorders. This patent review relates to progestin receptor agonists and antagonists, focusing on applications filed over the past three years. Two emerging themes will be elaborated upon: the development of novel steroidal and non-steroidal compounds, and the elucidation of new therapeutic uses for progestin antagonists.
引用
收藏
页码：955 / 962
页数：8
相关论文
共 50 条
  • [41] The influence of estrogens, progesterone and their antagonists on the collagen content in the pregnant rat uterus
    Bienkiewicz, A
    Welfel, J
    Kus, E
    HORMONE AND METABOLIC RESEARCH, 1996, 28 (11) : 592 - 594
  • [42] A new generation of progesterone receptor modulators
    Winneker, Richard C.
    Fensome, Andrew
    Zhang, Puwen
    Yudt, Matthew R.
    McComas, Casey C.
    Unwalla, Rayomond J.
    STEROIDS, 2008, 73 (07) : 689 - 701
  • [43] Progesterone receptor ligands for the treatment of endometriosis
    Clemenza, Sara
    Capezzuoli, Tommaso
    Eren, Ecem
    Garcia, Jose M. Garcia
    Vannuccini, Silvia
    Petraglia, Felice
    MINERVA OBSTETRICS AND GYNECOLOGY, 2023, 75 (03) : 288 - 297
  • [44] Progesterone receptor modulators in breast cancer
    Wiehle, Ronald D.
    TURKISH JOURNAL OF BIOLOGY, 2014, 38 (06) : 772 - 785
  • [45] CORTICOSTEROID RECEPTOR ANTAGONISTS - A CURRENT PERSPECTIVE
    SUTANTO, W
    DEKLOET, ER
    PHARMACY WORLD & SCIENCE, 1995, 17 (02): : 31 - 41
  • [46] Development of specific glucocorticoid receptor antagonists
    Belanoff, Joseph K.
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2012, 3
  • [47] Progesterone receptor isoform B in the human Fallopian tube and endometrium following mifepristone
    Sun, XX
    Christow, A
    Marions, L
    Gemzell-Danielsson, K
    CONTRACEPTION, 2003, 67 (04) : 319 - 326
  • [48] Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist
    Bungay, Peter J.
    Tweedy, Sarah
    Howe, David C.
    Gibson, Karl R.
    Jones, Hannah M.
    Mount, Natalie M.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (08) : 1396 - 1405
  • [49] Promising selective progesterone receptor modulators: what's new in female contraception?
    Nelson, Anita
    Shapiro, Marit Pearlman
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, : 1187 - 1198
  • [50] The progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesterone
    Check, J. H.
    DiAntonio, G.
    DiAntonio, A.
    Duroseau, M.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2016, 43 (02) : 189 - 191
12345